Neurofibromatosis type 1 surgery: Difference between revisions
Jump to navigation
Jump to search
MoisesRomo (talk | contribs) No edit summary |
MoisesRomo (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Surgery]] can be helpful for correction of some [[neurofibromatosis type 1]] bone malformations and for removal of painful or disfiguring [[tumors]]. | [[Surgery]] is only used as a [[palliative]], rather than curative [[therapy]]. [[Surgery]] can be helpful for the correction of some [[neurofibromatosis type 1]] bone malformations and for removal of painful or disfiguring [[tumors]]. | ||
==Surgery== | ==Surgery== | ||
*[[Surgery]] can be helpful for correction of some [[neurofibromatosis type 1]] [[bone]] [[malformations]] and for removal of painful or disfiguring [[tumors]]. | *[[Surgery]] can be helpful for correction of some [[neurofibromatosis type 1]] [[bone]] [[malformations]] and for removal of painful or disfiguring [[tumors]]. | ||
*After removal, there is a chance that the [[tumors]] may grow back and in greater numbers. | *After removal, there is a chance that the [[tumors]] may grow back and in greater numbers. | ||
*[[Surgery]] options for tumor removal include total and partial resections. | *[[Surgery]] options for tumor removal include total and partial resections. | ||
* In the rare instances when [[tumors]] become malignant (3- 5% of all cases), [[treatment]] may include [[radiation]], or [[chemotherapy]] in addition to [[surgery]]. <ref name="JAMApatient">[http://jama.ama-assn.org/cgi/content/full/300/3/352 Neurofibromatosis]. [[Journal of the American Medical Association|JAMA]] patient page, Vol. 300 No. 3, July 16, 2008.</ref> | *In the rare instances when [[tumors]] become malignant (3- 5% of all cases), [[treatment]] may include [[radiation]], or [[chemotherapy]] in addition to [[surgery]]. <ref name="JAMApatient">[http://jama.ama-assn.org/cgi/content/full/300/3/352 Neurofibromatosis]. [[Journal of the American Medical Association|JAMA]] patient page, Vol. 300 No. 3, July 16, 2008.</ref> | ||
* In cases where [[tumors]] are not progressing rapidly, conservative approach of watchful waiting is preferred. | *In cases where [[tumors]] are not progressing rapidly, the conservative approach of watchful waiting is preferred. | ||
<br /> | <br /> | ||
Latest revision as of 16:44, 1 September 2020
|
Neurofibromatosis type 1 Microchapters |
|
Differentiating Neurofibromatosis type 1 from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Neurofibromatosis type 1 surgery On the Web |
|
American Roentgen Ray Society Images of Neurofibromatosis type 1 surgery |
|
Risk calculators and risk factors for Neurofibromatosis type 1 surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Moises Romo M.D.
Overview
Surgery is only used as a palliative, rather than curative therapy. Surgery can be helpful for the correction of some neurofibromatosis type 1 bone malformations and for removal of painful or disfiguring tumors.
Surgery
- Surgery can be helpful for correction of some neurofibromatosis type 1 bone malformations and for removal of painful or disfiguring tumors.
- After removal, there is a chance that the tumors may grow back and in greater numbers.
- Surgery options for tumor removal include total and partial resections.
- In the rare instances when tumors become malignant (3- 5% of all cases), treatment may include radiation, or chemotherapy in addition to surgery. [1]
- In cases where tumors are not progressing rapidly, the conservative approach of watchful waiting is preferred.
References
- ↑ Neurofibromatosis. JAMA patient page, Vol. 300 No. 3, July 16, 2008.